Iadecola C. Neuron. 2013 Nov 20;80(4):844-66. View the full Webinar: See Costantino Iadecola’s
Our Webinar on 17 June 2013 covered the latest research and future directions on blood-based biomarkers discussed at a recent Alzheimer’s Drug Discovery Foundation/Alzheimer’s Association conference.
between AD pathology and microglial dysfunction. Alzforum held a Webinar on Thursday, 23 May 2013,
Administration shared his viewpoint and answered questions about the new guidance. Listen to the Webinar.
On 4 April 2013, the Alzheimer's Disease Neuroimaging Initiative biostatistics core held the first session of its two-part online training course on using ADNI data. Led by Danielle Harvey of the University of California, Davis, the session gave a br
β-blocker drugs used in humans. Alzforum held a Webinar in which Dennis Selkoe, Brigham and Women’s
on this "inflammation hypothesis of AD" could herald new directions in AD research and therapy. In this Webinar
and what makes a project attractive to funders in general. Resources mentioned during the Webinar
side effects. In this Alzforum Webinar, Taisuke Tomita, University of Tokyo, and Rui Peixoto, Harvard Medical
to set aside? On 31 July 2012, Alzforum held a Webinar led by Rita Guerreiro, University College, London, UK,
it in an Alzforum Webinar. Marc Diamond, Washington University, St. Louis Missouri; Jorge Sepulcre, Massachusetts
unlike those whose scans were negative. Kawas recorded her talk on Alzforum’s Webinar platform to share
and in a Webinar with some of the developers of an international and a U.S. set of criteria (see ARF Webinar
Alzforum held a Webinar discussion on the topic. Gael Chételat was joined by Anna Caroli, Keith Johnson,
on our Webinar platform to share it with the wider global research community. For more background, see ARF related conference story. The Webinar recording below anchored Alzforum’s CTAD 2011 coverage. Play
Have a topic idea for a webinar? We would love to hear it. Send an email to webinars [at] alzforum [dot] org.